Human Reproduction, Vol. 14, No. 8, 2139-2142,
August 1999
© 1999 European Society of Human Reproduction and Embryology
The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial
Department of Obstetrics and Gynaecology, University of Hong Kong, Queen Mary Hospital, Hong Kong
Misoprostol is effective for cervical priming prior to vacuum aspiration for first trimester termination of pregnancy. Previous studies showed that the oral route was more acceptable to patients but there were higher incidences of side-effects when compared with the vaginal route. This study is to determine the optimal dosage and route of administration of misoprostol for pre-operative cervical dilatation. A double-blind, randomized trial was undertaken for 225 nulliparous women with 8–12 weeks amenorrhoea. They were randomly assigned to groups given 0 (placebo), 200 or 400 µg oral or vaginal misoprostol 3 h prior to vacuum aspiration. In misoprostol-treated groups the baseline cervical dilatation was significantly increased when compared with the placebo group; the effect was dose-related in the oral but not in the vaginal group. The cumulative force and blood loss was significantly decreased in the misoprostol-treated groups. The incidences of side-effects were more frequent in misoprostol groups but were not related to the route and dosage of medication. The duration of procedure, incidences of post-operative complications, the duration of post-operative bleeding and the interval to the first period were similar in the five treatment groups. We conclude that a 3 h pre-treatment interval is effective for both oral and vaginal routes. When given orally, 400 µg is more effective than 200 µg. The efficacy was otherwise similar when compared with the vaginal route. We recommend 400 µg oral misoprostol 3 h prior to vacuum aspiration for cervical dilatation.
Key words: cervical priming/misoprostol/oral/vaginal
1 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Saav, A. Aronsson, L. Marions, O. Stephansson, and K. Gemzell-Danielsson Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial Hum. Reprod., October 1, 2007; 22(10): 2647 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Y. Kan, N. Caves, S. Y. W. Wong, E. H. Y. Ng, and P. C. Ho A double-blind, randomized controlled trial on the use of a 50:50 mixture of nitrous oxide/oxygen in pain relief during suction evacuation for the first trimester pregnancy termination Hum. Reprod., October 1, 2006; 21(10): 2606 - 2611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiala, M.L. Swahn, O. Stephansson, and K. Gemzell-Danielsson The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation Hum. Reprod., November 1, 2005; 20(11): 3072 - 3077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.C.W. Chan, O.S. Tang, E.H.Y. Ng, C.F. Li, and P.C. Ho Intracervical sodium nitroprusside versus vaginal misoprostol in first trimester surgical termination of pregnancy: a randomized double-blinded controlled trial Hum. Reprod., March 1, 2005; 20(3): 829 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Fernandez, J.D. Alby, C. Tournoux, A. Chauveaud-Lambling, R. deTayrac, R. Frydman, and R. Porcher Vaginal misoprostol for cervical ripening before operative hysteroscopy in pre-menopausal women: a double-blind, placebo-controlled trial with three dose regimens Hum. Reprod., July 1, 2004; 19(7): 1618 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. Tang, K. H. Mok, and P. C. Ho A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester Hum. Reprod., May 1, 2004; 19(5): 1101 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aronsson, M. Bygdeman, and K. Gemzell-Danielsson Effects of misoprostol on uterine contractility following different routes of administration Hum. Reprod., January 1, 2004; 19(1): 81 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.Y.G. Wong, E.H.Y. Ng, S.W. Ngai, and P.C. Ho A randomized, double blind, placebo-controlled study to investigate the use of conscious sedation in conjunction with paracervical block for reducing pain in termination of first trimester pregnancy by suction evacuation Hum. Reprod., May 1, 2002; 17(5): 1222 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. Tang, H. Schweer, H.W. Seyberth, S. W.H. Lee, and P. C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum. Reprod., February 1, 2002; 17(2): 332 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.W. Ngai, Y.M. Chan, and P.C. Ho The use of misoprostol prior to hysteroscopy in postmenopausal women Hum. Reprod., July 1, 2001; 16(7): 1486 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Ngai, Y. M. Chan, O. S. Tang, and P. C. Ho Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage Hum. Reprod., July 1, 2001; 16(7): 1493 - 1496. [Abstract] [Full Text] [PDF]
|
|